TGF-β behavior in the progressive process in the focal glomerulosclerosis rat model: The role of latent TGF-β-binding protein

Contributions to Nephrology

Volumn 118, Issue , 1996, Pages 78-85

  Okuda, Seiya ^a   Tamaki, Kiyoshi ^a   Ando, Takashi ^a   Yanagida, Taihei ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DOXORUBICIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; MESSENGER RNA; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; FOCAL GLOMERULOSCLEROSIS; GENETICS; MALE; METABOLISM; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CARRIER PROTEINS; DOXORUBICIN; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029686162     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (14)

1. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
2. 1 in glomerulosclerosis and interstitial fibrosis of Adriamycin nephropathy. Kidney Int 1994;45:525-536.
3. 1. Purification from human platelets and structural characterization. J Biol Chem 1988;263:6407-6415.
4. Tsuji T, Okada F, Yamaguchi K, Nakamura T: Molecular cloning of the large subunit of transforming growth factor-β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA 1990;87:8835-8839.
5. Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S: Lack of the latent transforming factor-β binding protein in malignant, but not benign prostatic tissue. Cancer Res 1993;53:183-190.
6. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M: Adriamycin-induccd nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986;29:502-510.
7. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel J, Heldin CH, Rifkin DB: Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993;120:995-1002.
8. Dallas SL, Park-Synder S, Miyazono K, Twardzik DR, Mundy GR, Bonewald LF: Characterization and autoregulation of latent transforming growth factor-β complexes in osteoblast-like cell lines. J Biol Chem 1994;269:6815-6822.
9. Mizoi T, Ohtani H, Matsuno S, Nagura H: Immunohistochemical identification of transforming growth factor-β and its binding protein in human gastrointestinal carcinoma. Tohoku J Exp Med 1992;168:271-273.
10. 1, associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 1994;124:171-181.
11. 1. EMBO J 1991;10:1091-1101.
12. Wolf G, Mueller E, Stahl RA, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366-1372.
13. Law F, Rizzoli R, Bonjour JP: Transforming growth factor-β inhibits phosphate transport in renal epithelial cells. Am J Physiol 1993;264:F623-F628.
14. Lin HY, Wang XF, Ng EE, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992;68:775-785.